Who is sponsoring NCT02708459?

NCT02708459 is sponsored by AlRefaey Kandeel.

What drugs are being tested in NCT02708459?

Interventions in NCT02708459: surgically inserted Transversus abdominus plane catheter, Intravenous morphine, Bupevecaine, Dexmedetomedine.

What condition does NCT02708459 study?

NCT02708459 studies Living Donor Hepatectomy.

Is NCT02708459 still recruiting?

NCT02708459 is currently completed. Last updated 29 August 2016.

Last reviewed 2016-08-29 · How we verify

NCT02708459: TAP Donor

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Transversus Abdominus Plane Block in Living Donor Hepatectomy

Completed NA Last updated 29 August 2016

What this trial tests

NA trial testing surgically inserted Transversus abdominus plane catheter in Living Donor Hepatectomy in 90 participants. Completed in 1 August 2016.

Timeline

1 March 2016

Primary endpoint
1 August 2016

1 August 2016

Quick facts

Lead sponsor	AlRefaey Kandeel
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	90
Start date	1 March 2016
Primary completion	1 August 2016
Estimated completion	1 August 2016
Sites	2 locations across Egypt

Drugs / interventions tested

surgically inserted Transversus abdominus plane catheter
Intravenous morphine — full drug profile →
Bupevecaine — full drug profile →
Dexmedetomedine — full drug profile →

Conditions studied

Living Donor Hepatectomy — all drugs for Living Donor Hepatectomy →

Sponsor

AlRefaey Kandeel — full company profile →

Who can join

Adults 18 to 45, any sex, with Living Donor Hepatectomy. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

postoperative morphine (mg) consumption in 1st 48 hours
Time frame: 48 hours postoperative

Sponsor's own description

Comparing different drugs used in Transversus abdominus plane analgesia after donor hepatectomy. Patients will be divided into three groups; control group, Bupivecaine group, and Dexmedetomedine group according to the used drug

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Dexmedetomidine in a surgically inserted catheter for transversus abdominis plane block in donor hepatectomy: A prospective randomized controlled study.
Aboelela MA, Kandeel AR, Elsayed U, Elmorshedi M, et al · · 2018 · cited 2× · PMID 29628844 · DOI 10.4103/sja.sja_577_17

Verify or expand the search:

Other AlRefaey Kandeel trials

Trials by the same sponsor.

NCT03443947 — Modified Mallampati Scoring Technique for Airway Assessment · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02708459 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by AlRefaey Kandeel
Last refreshed: 29 August 2016

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02708459.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing